Liso-Cel Produces Deep, Durable Responses in Patients with Hard-to-Treat Lymphomas
June 22nd 2023Treatment with lisocabtagene maraleucel led to strong and durable response rates with little serious adverse effects in patients with relapsed or refractory follicular lymphoma and mantle cell lymphoma.
Read More
Experts Discuss Expanding the Role of the Pharmacist in Public Health
June 22nd 2023Christina Madison, PharmD, FCCP, AAHIVP, sat down with Sandra Leal, PharmD, MPH, FAPhA, CDCES, vice president of pharmacy practice innovation and advocacy at CVS Pharmacy, to discuss how pharmacists are diving into public health and expanding their roles.
Watch
ACIP Votes to Recommend Use of Arexvy for Respiratory Syncytial Virus in Older Adults
June 22nd 2023CDC Advisory Committee on Immunization Practices recommends the use of respiratory syncytial virus (RSV) vaccine, adjuvanted (Arexvy) for adults 60 years of age and older based on findings from the first season of the pivotal AReSVi-006 (Adult Respiratory Syncytial Virus) phase III trial.
Read More
Ensuring Innovation Act Changes Eligibility for New Chemical Exclusivity
Law aims to encourage competition in the pharmaceutical industry, making it easier for generics to enter market.
Read More
CMS 2024 Final Rule Includes Surprises, Opportunities for Pharmacies and Payers
June 21st 2023Among health care professionals, pharmacists are best suited to serve as trusted partners for patients to help ensure they understand their medication regimen, identify medication-related problems, and work with prescribers to close gaps in care.
Read More
Common Antibiotics Associated with C. difficile Infection Include Piperacillin, Meropenem
June 21st 2023Antibiotics that were found to be most commonly associated with clostridium difficile infection are piperacillin/tazobactam, meropenem, vancomycin, ciprofloxacin, ceftriaxone, and levofloxacin, according to a recent study.
Read More